Newsletter | July 23, 2021

07.23.21 -- Why NervGen Is Our Company To Watch

Companies To Watch: NervGen Pharma

NervGen Pharma is going beyond preclinicals to human trials for a drug that could repair and regrow neurons.

Closing The Health Leadership Gender Gap

Women make up 65% of workers in the health sector and are responsible for approximately 80% of consumer buying and healthcare decisions in the United States. Yet they make up barely one-third of senior leadership positions within the industry and only 13% of CEOs.

Biopharma Innovators: The Challenges And Opportunities

Biopharma companies are predicted to provide 85% of drugs within a decade. Yet small and midsize biopharmas face the challenge of marketing their innovations in a context of uneven distribution of funding, geopolitical battles, and suboptimal supply chains.

First-Time CEOs: Firsthand Tales Of The Good, The Bad, And The Ugly

Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly. In this executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals, Frank Lee, CEO, Forma Therapeutics, and Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO, Vigil Neuroscience.

Special Edition #11: Making Diversity And Inclusion A Best Business Practice

Diversity and inclusion is — and has been — an important issue for the biopharmaceutical industry. As such, we thought it would be worthwhile to gain some perspective.

Web-Exclusive Content
Leaders Have An Appetite For Adaptability When Outsourcing
In part one — "Five Maxims For Outsourcing Success" — we tackled Lisa Wyman's first three of five tenets to better outsource by. Here we explore her belief that leveraging capabilities and capacities of CDMOs is predicated on an appetite for adaptability and flexibility, and that is exhibited as a quality of leadership.
July 2021 Digital Edition

Inside you will find more on:

  • From R&D To Phase 3
  • AI And ML In Drug Discovery
  • Leadership Lessons
  • Ask The Board

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.